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Hearing impairment affects about 1 in 1000 newborns. Mutations in the connexin 26 (GJB2) 
gene rank among the most frequent causes of non-syndromic deafness in different populations, 
while delGJB6-D13S1830 mutation located in the DFNB30 locus is known to cause sensorineural 
hearing loss. Despite the many studies on the involvement of GJB2 mutations in hearing impair-
ment in different populations, there is little information on genetic deafness in Brazil, especially in 
the Amazon region.
Objective: To determine the prevalence of GJB2 mutations and delGJB6-D13S1830 in 77 sporadic 
non-syndromic deaf patients.
Method: The coding region of the GJB2 gene was sequenced and polymerase chain reaction was 
performed to detect the delGJB6-D13S1830 mutation.
Results: Mutant allele 35delG was found in 9% of the patients (7/77). Mutations M34T and V95M 
were detected in two distinct heterozygous patients. Non-pathogenic mutation V27I was detected 
in 28.6% of the patients (22/77). None of the deaf patients carried the delGJB6-D13S1830 mutation.
Conclusion: Mutant alleles on gene GJB2 were observed in 40% (31/77) of the subjects in the 
sample. Pathogenic variants were detected in only 12% (9/77) of the individuals. More studies are 
required to elucidate the genetic causes of hearing loss in miscegenated populations.
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INTRODUCTION
Hearing impairment affects about 1 in 1000 new-
borns1. Deafness can be due to either genetic or environ-
mental causes or a combination of both. In developed 
countries, about 60% of all cases are related to genetic 
origin2. It has been estimated that 30% of genetic deafness 
cases are syndromic and 70% are non-syndromic3. In Brazil, 
the frequency of non-syndromic congenital deafness is 
approximately four in 1000 births, 16% of which are of 
genetic etiology4. Within the hereditary non-syndromic 
hearing loss category, autosomal recessive forms (DFNB) 
make up about 75-80% of all cases, autosomal dominant 
forms (DFNA) about 20%, X-linked forms (DFN) 2-5%, and 
mitochondrial forms about 1%5. To date, more than 120 
different loci have been estimated to be involved in deaf-
ness and 70 genes have been identified and characterized6.
The GJB2 locus has been reported to be the major 
cause of autosomal recessive non-syndromic sensorineural 
deafness (ARNSD)3,7,8. GJB2 gene mutations have been 
associated to 50% of autosomal recessive non-syndromic 
deafness in many populations9,10. More than 101 different 
mutations in connexin 26 gene are known to be associated 
with hearing impairment11. The prevalence of some GJB2 
mutations differs considerably among ethnic groups. The 
35delG mutation is the most common variant in European 
populations12,13. The carrier frequency of 35delG ranges 
between 0.97% and 2.24% in the southeastern region of 
Brazil14,15. In São Paulo state, the 35delG mutation was the 
most frequent (12.4%)16; it was found in 23% of the family 
cases, and 6.2% of the simplex cases. The 235delC muta-
tion is predominant in Asian populations as a whole17-21, 
whereas the 167delT mutation is also frequent in Ashkenazi 
Jewish population22-24.
It is known that GJB6 mutations are a com-
mon cause of deafness25. A deletion of 243Kb named 
delGJB6-D13S1830 mutation in GJB6 gene is the second 
most frequent genetic cause of non-syndromic prelingual 
hearing impairment in the Spanish population26. It has also 
been described among Ashkenazi Jews27 and in French 
non-syndromic hearing loss patients28.
Some studies have reported the genetic frequency 
of GJB2 mutations and delGJB6-D13S1830 mutation re-
lated with non-syndromic deafness in Brazilian popula-
tions12,16,29-31. North Brazilian populations are composed of 
a highly interethnic admixture with an added European 
gene contribution32 and no previous data are available 
for the allelic variants in GJB2 or the frequency of the 
delGJB6-D13S1830 mutation in the Amazon region. In 
order to establish the prevalence of GJB2 mutations 
among deafness patients in this region, we investigated 
77 simplex cases of prelingual non-syndromic hearing 
impairment. Additionally, we investigated the prevalence 
of the delGJB6-D13S1830 deletion.
METHOD
This study was approved by the Research Ethics 
Committee of João de Barros Barreto University Hospital 
(protocol n. 2241/05).
Subjects and clinical evaluation
The study was conducted on seventy-seven chil-
dren with prelingual non-syndromic hearing loss. All 
seventy-seven probands were unrelated and simplex 
cases of deafness. Samples were obtained from a School 
for the Deaf in Belém, Pará, Brazil. Syndromic patients 
were not included in this study. All the seventy-seven 
children were severe-to-profound prelingual hearing 
impairment cases. For each child, the complete medical 
history and questionnaires were administered to ensure 
that hearing loss was not the result of environmental 
causes: maternofetal infection, perinatal complica-
tions, meningitis, mumps, prenatal, prolonged use of 
antibiotics/drug ototoxicity and acoustic trauma. All 
children underwent an otoscopy, audiovestibular tests 
and available audiometry, and a general examination 
including systematic examination of syndromic form 
was evaluated. Written informed consent was obtained 
from all the patients’ parents.
Molecular Analysis
DNA was extracted from EDTA anticoagulated 
whole blood using the phenol-chloroform method and 
precipitation with ethanol. To identify GJB2 mutations, 
a DNA fragment containing the entire coding region was 
amplified using the primer pair in Polymerase Chain Reac-
tion (PCR) and two additional internal primers were used 
in the DNA sequencing of Cx26: GJB2-1F (5´-GTGTTG-
TGTGCATTCGTCTTTTC-3´) forward primer for PCR and 
sequencing; GJB2-2R (5´-CCTCATCCCTCTCATGCTGTC-
TA-3´) reverse primer for PCR and sequencing; GJB2-4F 
(5´-GGAAGTTCATCAAGGGGGAGATA-3´) primer for 
internal forward sequencing, and GJB2-3R (5´-ACCTTC-
TGGGTTTTGATCTCC TC-3’) primer for internal reverse 
sequencing.
PCR conditions were for 35 cycles with denatu-
ration at 94°C for 1 min, annealing at 60°C for 1 min 
and extension at 72°C for 1 min. In all cases of GJB2 
gene analysis, bi-directional DNA sequencing was 
performed and in some cases internal primers were 
used to confirm the result. They were sequenced on 
an ABI Prism Big-Dye Terminator Cycle Sequencing 
KitTM (Applied Biosystems) and electrophoresed on an 
ABI Prism 377 DNA Sequencer (Applied Biosystems). 
PCR amplification of delGJB6-D13S1830 mutation was 
performed by using primers and conditions previously 
described26.
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RESULTS
The results are summarized in Table 1. Analysis of 
the complete coding region of GJB2 gene of 77 hearing-
-impaired children revealed four different mutations pre-
viously described: 35delG, M34T, V95M and V27I. Allele 
variants in GJB2 gene were found in 40% of all cases 
(31 of the 77 patients). The most common mutation was 
V27I and detected in 22 patients: twenty individuals were 
heterozygous and two were homozygous. However, V27I 
mutation was previously reported to be a polymorphism 
without pathological effects and unrelated to hearing loss17. 
Pathogenic mutations were observed in 12% of patients. 
The 35delG mutation was detected in seven (9%) of the 
patients: one was homozygous and six patients were 
heterozygous, in which the second GJB2 mutation was 
not found. The 35delG mutation accounted for 8 out of 
10 GJB2 mutated pathogenic alleles. Two other missense 
mutations were observed, V95M and M34T, in two dis-
tinct heterozygous patients with the second allele being 
normal. In addition, screening for the del(GJB6-D13S1830) 
mutation was negative in all 77 patients.
by different authors as a polymorphism, a causative re-
cessive or dominant mutation8,36-40. In a UK population 
study, the M34T mutation is in keeping with its classi-
fication as a mutation causing mild/moderate hearing 
loss in homozygosity or compound heterozygosity. This 
adds further evidence that M34T is a mild but functional 
variant with a larger effect in the 35delG group41. Another 
study of Finnish population support the hypothesis that 
the M34T is a pathogenic mutation and displays an au-
tosomal recessive pattern of inheritance associated with 
mild to moderate non-syndromic sensorineural hearing 
impairment in the homozygous state42.
The M34T was reported in the South American 
population43 and Brazil16. The V95M mutation was 
observed in only one heterozygous patient. The missense 
mutation converts the amino acid valine to methionine at 
codon 95. Valine is invariant at this position in all known 
alpha and beta connexin genes28. V95M is reported to 
be much rarer44. It has been reported in one compound 
heterozygous patient with non-syndromic hearing 
impairment in a southeastern Brazilian population29. Of 
all GJB2 mutations detected in our study, the V27I is the 
most frequent. This mutation is considered polymorphism 
and a non-pathological change related to hearing loss17,22. 
It is rarely observed in the North American population22. 
However, it is frequent among Asian populations, such as 
Chinese45; Japanese17; Korean46 and in Asian background 
population47. In a previous study among Brazilian patients, 
V27I mutation was found in two unrelated heterozygous 
individuals out of twenty-six sporadic cases29.
Given the high prevalence of V27I mutation, we 
raised the hypothesis that it resulted from the increased 
contribution of Amerindian genes in northern Brazilian 
populations32. To address the question, we investigated the 
frequency of the V27I mutation in a sample composed of 
400 hearing individuals from Belém population. The results 
(unpublished data) demonstrated that the frequency of 
the V27I mutation among hearing individuals from Belém 
population is high (12.4%) and similar to the frequency 
of this mutation in the deaf patients investigated (15.5%). 
These frequencies are similar to those described in China45 
and higher than in European populations. Thus, the Ame-
rindian populations are probably the original source of the 
V27I mutation in the research sample.
delGJB6-D13S1830 mutation is the second most 
frequent genetic cause of non-syndromic prelingual 
hearing impairment in the Spanish population and a 
digenic pattern of inheritance involving GJB2 mutations 
and delGJB6-D13S1830 mutation in GJB6 gene is sug-
gested26. Additionally, del(GJB6-D13S1830) allele was 
found in 7.1% of Brazilian deaf patients26. In another 
study, the del(GJB6-D13S1830) mutation was observed 
in only one compound heterozygous patient (35delG/
del(GJB6-D13S1830) from Brazil´s southeastern region30. 
Table 1. GJB2 mutations detected in Belém, state of Pará, Brazil.
Genotypes No. of samples (%) Mutation type
35delG/35delG 1 1.3%
Frameshift
35delG/Wt 6 7.8%
M34T/Wt 1 1.3% Missense
V95M/Wt 1 1.3% Missense
V27I/V27I 2 2.6% Missense 
(Polymorphism)V27I/Wt 20 26%
Normal (Wt/Wt) 46 59.8%
Total 77
DISCUSSION
This study is the first of its kind, describing the 
prevalence of GJB2 and GJB6 variants in Amazon po-
pulation. Several studies have shown that the 35delG 
mutation is present in different ethnic and geographic 
groups, and accounted for up to 80% of GJB2 mutations33. 
A previous study revealed a frequency of 2.1% for 35delG 
mutation in the northern region of Brazil34. Although our 
work was based on small numbers of patients, the results 
may confirm the importance of GJB2 mutations in the 
etiology of hearing impairment in Belém - PA. This study 
shows that the 35delG mutation is the most common 
pathogenic GJB2 allele. The 35delG mutant allele was 
found in 9% of the patients, which is in agreement with 
findings in previous studies of Brazilian population29,30,35. 
The pathological significance of the M34T mutation has 
been discussed. It was firstly associated with dominant 
hearing loss at DFNA38. However, it has been reported 
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In this work, the screening of 77 patients did not reveal 
this mutation and our results cannot suggest risk of hea-
ring impairment due to del(GJB6-D13S1830) mutation in 
our population.
CONCLUSION
GJB2 mutated alleles were observed in 40% (31/77) of 
Amazonian deaf patients. However, the pathogenic variants 
(35delG, M34T and V95M) have been detected in 12% (9/77) 
of the cohort and are known to act in a recessive manner. 
Among nine patients with pathogenic mutations, eight carry 
only one mutation in the GJB2 coding sequence, although 
the whole coding region of GJB2 gene was sequenced in all 
samples by a bi-directional DNA sequencing, including the 
35delG heterozygous. The putative second mutation in these 
patients could be located in non-analysed areas in GJB2 
gene such as splice sites. The hypothesis that the second 
mutation located in a second gene can not be ruled out.
The results of this pilot study should contribute to 
the development of the genetic diagnosis of deafness and 
could be important for public health issues, precise genetic 
counselling, and early treatment in this region. Moreover, 
further studies and research are needed to find out and 
analyse genes and variants to elucidate other genetic causes 
of hearing impairment in mixed populations.
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